The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women
article
OA: bronze
CC0
⤵ 7 in-corpus citations
Abstract
OBJECTIVE: Levonorgestrel releasing intrauterine system (LNG-IUS) has been shown to treat patients with non-atypical & atypical endometrial hyperplasia (EH) successfully in many western studies. Our purpose was to examine the effectiveness of LNG-IUS in the treatment of Korean women with EH. METHODS: We conducted a prospective observational study of 12 women diagnosed with EH and treated with LNG-IUS insertion between February 2007 and August 2009 at the Department of Gynecology of Gangnam CHA Hospital, CHA University School of Medicine. Baseline endometrial biopsies were done before insertion of LNG-IUS, and outpatient follow-up endometrial biopsies were undertaken at 3-month intervals after insertion of LNG-IUS. We investigated the regression rate and the time to regression. RESULTS: Four patients had simple hyperplasia without atypia, 7 patients complex hyperplasia without atypia, and just 1 patient complex atypical hyperplasia. Complete regression of EH was achieved in all cases (100%, 12/12), with the significant proportion (66%, 8/12) achieving it within 3 months. The mean duration to regression was 4.5 months. All cases had regression within 9 months. In the case of complex atypical hyperplasia, the regression was attained at the 9th month after insertion of LNG-IUS. The mean follow-up duration was 12 months (range, 3 to 27 months). As long as LNG-IUS was maintained, the EH did not recur. CONCLUSION: LNG-IUS appears to be as highly effective in treating Korean women with EH.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: Long-term follow-up via openalex
- The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology via openalex
- doi:10.1016/j.ejogrb.2005.09.004 via openalex
- doi:10.1002/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x via openalex
- doi:10.1007/s004040000151 via openalex
- doi:10.1016/j.ygyno.2003.07.002 via openalex
- doi:10.1016/0002-9378(89)90103-8 via openalex
- W1502815966 via openalex
- doi:10.1053/beog.2000.0184 via openalex
- doi:10.1097/00006254-200405000-00025 via openalex
- doi:10.1016/s0015-0282(03)01183-x via openalex
- doi:10.1016/j.ygyno.2005.10.030 via openalex
- doi:10.1016/j.ygyno.2008.06.014 via openalex
- doi:10.1111/j.1447-0756.1997.tb00836.x via openalex
- doi:10.1016/j.ejogrb.2008.02.022 via openalex
Cited by (7)
- Vaginal micronized progesterone versus the levonorgestrel‐releasing intrauterine system for treatment of non‐atypical endometrial hyperplasia: A randomized controlled trial 2022
- Clinical Use of Progestins and Their Mechanisms of Action: Present and Future (Review) 2021
- Medical Management of Heavy Menstrual Bleeding 2015
- Levonorgestrel-Releasing Intrauterine Device Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia 2014
- Efficacy of the Levonorgestrel-Releasing Intrauterine Device as an Alternative to Oral Progesterone in the Management of Endometrial Hyperplasia without Atypia 2014
- LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial 2013
- Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases 2013
Source provenance
- openalex
- last seen: 2026-05-10T10:38:40.447481+00:00
License: CC0
· commercial use OK